MIT-001

MIT-001 · MitoImmune Therapeutics

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MIT-001, covering 2024-05-29 to 2025-04-06. Get the full timeline:

Most recent: Clinical Trial Update: MIT-001 for Prevention of CCRT-Induced OM in HNSCC Patients [Phase 2]